Gefitinib-Induced Hepatotoxicity in Patients Treated for Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 509-513

Karger

Access to resources Recommend Favorite

Acute Myocardial Infarction with Lung Cancer during Treatment with Gefitinib: the Possibility of Gefitinib-Induced Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 1, 2005-11 ,pp. : 48-50

Karger

Access to resources Recommend Favorite

Erlotinib Achieved Partial Response in a Non-Small Cell Lung Cancer Patient with Gefitinib-Induced Interstitial Lung Disease

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 464-466

Karger

Access to resources Recommend Favorite

Association between concomitant psychiatric drug use, and patients' beliefs about and persistence with chronic cardiovascular medication

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 3, 2015-03 ,pp. : 328-335

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatotoxicity induced by alendronate therapy

By Yanık B.   Turkay C.   Atalar H.  

Osteoporosis International, Vol. 18, Iss. 6, 2007-06 ,pp. : 829-831

Springer Publishing Company

Access to resources Recommend Favorite